Table 3.
Performance of Samrakshan for period July 1, 2019, to September 1, 2019
| First Trimester | n, % |
|---|---|
| Number of Women Screened | 58 |
| High risk for PE (n, %) | 10 (17.24%) |
| High risk for FGR (n, %) | 29 (50%) |
| Recommended Low dose Aspirin (n, %) | 30 (51.72%) |
| Third Trimester Singletons | |
| Number of women Screened | 131 |
| Women with PE (n, %) | 2 (1.53%) |
| Prior high risk for PE (n, %) | 2 (1.53%) |
| EFW centiles <3 (n, %) | 6 (4.58%) |
| EFW Centiles 3-10 (n, %) | 8 (6.11%) |
| FGR stage 1 (n, %) | 9 (6.87%) |
| FGR stage 2 (n, %) | 0 |
| FGR stage 3 (n, %) | 1 (0.76%) |
| FGR stage 4 (n, %) | 0 |
| No FGR (n, %) | 121 (92.31%) |
| EFW 3-10 centile with normal Doppler (n, %) | 6 (75%) |
| EFW 10-50 centile with abnormal Doppler | 20 (46.51%) |
| Mean UtA PI >95th centile | 21 (16.03%) |
| CPR <5th centile | 21 (16.03%) |
| Online courses | |
| Number of registrants first trimester | 214 |
| Number of registrants third trimester | 37 |
| Number case discussions posted | 3 |
| Number Instructors | 17 |
| Number research articles shared | 7 |
| IRIA Samrakshan page visits | 2047 (1994 from India) |
| Research protocols developed for Faculty/ Resident/Practitioner studies |
7 |
| State-level CME | 1 |